Part of Gilead's coronavirus drug donation allocated to Japan

Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc's coronavirus drug remdesivir, days after granting emergency approval to the medication the company is supplying as part of its pledged donation.